PIK3CA and neoplasm: reported that no definite conclusions could be drawn regarding survival of DFS or OS between the cohorts with PIK3CA wild‐type versus mutant tumours in GeparQuattro, GeparQuinto and GeparSixto studies.7, 8, 9